for subscribers

New DNA test can aid faster detection and treatment of pneumonia in patients with severe Covid-19

Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Unsplash

Many patients with severe forms of Covid-19 require intensive care unit (ICU) treatment and mechanical ventilation. As a result, these patients are at a higher risk of developing ventilator-associated pneumonia (VAP) because of prolonged sedation and bacteria patients are exposed to in hospitals.  

A team of researchers from the University of Cambridge and the Addenbrooke’s Hospital aimed to identify and compare VAP in ventilated Covid-19 patients to other ventilated patients without Covid-19. 

During their study, the researchers developed a DNA test which can quickly identify secondary infections in Covid-19 patients who are at an increased risk of developing pneumonia. The results of the study were recently published in the journal Critical Care.

There’s more to this story
Subscribe to News24 and get access to our exclusive journalism and features today.
Subscribe
Already a subscriber? Sign in